Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Palatin receives grants for the development of peptide-based therapeutics and diagnostics

Oct. 11, 1996

Geron licenses technologies for use in the treatment of age-related diseases

Oct. 11, 1996

Patent coverage for new gene expression system

Oct. 11, 1996

Patent allowance for SuperGen technology for cancer drug formulation

Oct. 11, 1996

Alkermes' RMP-7 advances through clinical trials

Oct. 11, 1996

First U.S. launch of product using Scherer's Zydis technology

Oct. 11, 1996

Inex and Schering-Plough extend collaboration on gene delivery systems

Oct. 11, 1996

Important milestone reached in Pharmacopeia-Schering-Plough collaboration

Oct. 11, 1996

Dyax grants additional licenses for phage display technology

Oct. 11, 1996

ArQule-Roche Bioscience collaborative agreement

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...